Gina Chapman - Nov 9, 2023 Form 3 Insider Report for CARGO Therapeutics, Inc. (CRGX)

Role
President & CEO, Director
Signature
/s/ Halley Gilbert, as attorney-in-fact for Gina Chapman
Stock symbol
CRGX
Transactions as of
Nov 9, 2023
Transactions value $
$0
Form type
3
Date filed
11/9/2023, 04:49 PM
Previous filing
Sep 5, 2023
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRGX Common Stock 104K Nov 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRGX Stock Option (Right to Buy) Nov 9, 2023 Common Stock 560K $5.03 Direct F1, F2
holding CRGX Stock Option (Right to Buy) Nov 9, 2023 Common Stock 169K $5.03 Direct F1, F3
holding CRGX Stock Option (Right to Buy) Nov 9, 2023 Common Stock 315K $5.03 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a 1-for-13.5685 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement on November 3, 2023.
F2 25% of the shares subject to the option vest on the first anniversary measured from February 9, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F3 25% of the shares subject to the option vest on the first anniversary measured from July 7, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F4 25% of the shares subject to the option vest on the first anniversary measured from October 27, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Exhibit 24.1 - Power of Attorney